myelomasociety.org
Categoria: Business
99
/ 100 Pontuação de confiança
Com base nos resultados da análise no momento da verificação
Nenhuma ameaça encontrada
Este site é seu?
Mostre aos visitantes que o seu site é seguro
Adicione o PCrisk Trust Badge, analisado novamente a cada 24 horas para malware & ameaças. Um selo de segurança visível transmite confiança aos visitantes, e essa confiança pode traduzir-se em mais vendas, registos e chamadas.
Reanálises automáticas
Verificado por mais de 90 motores de segurança
WordPress · Shopify · Wix · qualquer site
Obter o seu Trust Badge
Copiar e colar · configuração rápida
Verificações de segurança da PCrisk nos seus resultados do Google
Adicione a PCrisk como fonte preferida e os nossos relatórios de análise e guias de remoção terão prioridade no Google.
Adicionar PCrisk como fonte preferida
Captura de ecrã de myelomasociety.org
Capturada 17 de ago. de 2026
https://myelomasociety.org
16 anos
Sem classificação - Este site não aparece na lista Tranco
Não listado (91 verificados)
✓ Válido (TLS)
Google Cloud (us-east1)
North Charleston, United States
nginx
WordPress
104.196.208.135
Informações do domínio e WHOIS
Registrador
Squarespace Domains II LLC
Registado
16 de dezembro de 2009
Expira
16 de dezembro de 2026
Servidores de nomes
ns-cloud-a2.googledomains.com
DNSSEC
Assinado
Alojamento
Google Cloud (us-east1)
Reputação e verificação de ameaças
91 motores de segurança verificados
0
Não assinalado
Fontes diretas de bases de dados de ameaças
Google
Não listado
Spamhaus DBL
Não listado
SURBL
Não listado
Spamhaus ZEN
Não listado
Barracuda
Não listado
SpamCop
Não listado
Spamhaus ZRD
Não listado
URLhaus
Não listado
Phishtank
Não listado
QBMA
Não listado
Ver resultados detalhados dos motores no VirusTotal
Resumo da análise do ficheiro
Com tecnologia Quttera Engine
61 ficheiros analisados
Sem ameaças
61
Baixo risco
0
Risco médio
0
Alto risco
0
Sem ameaças
Baixo risco
Risco médio
Alto risco
www.myelomasociety.org.http-redirect
96 B
Sem ameaças
www.myelomasociety.org/?page_id=2928&preview=true
217.2 KB
Sem ameaças
www.myelomasociety.org/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/#
312.7 KB
Sem ameaças
www.myelomasociety.org/education/#
145.0 KB
Sem ameaças
www.myelomasociety.org/imsound/#
156.2 KB
Sem ameaças
www.myelomasociety.org/translational-research-award/#
220.5 KB
Sem ameaças
www.myelomasociety.org/donate/#
183.9 KB
Sem ameaças
www.myelomasociety.org/publications/#
145.3 KB
Sem ameaças
www.myelomasociety.org/glo-ims/#
142.2 KB
Sem ameaças
Mostrar mais 51...
www.myelomasociety.org/events/#
156.3 KB
Sem ameaças
www.myelomasociety.org/advocacy/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/advocacy/#
142.6 KB
Sem ameaças
www.myelomasociety.org/awards/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/awards/#
142.7 KB
Sem ameaças
www.myelomasociety.org/contact/#
141.6 KB
Sem ameaças
www.myelomasociety.org/ims-news-room/#
144.0 KB
Sem ameaças
www.myelomasociety.org/ims-connect/#
145.2 KB
Sem ameaças
www.myelomasociety.org/meeting-materials/#
142.0 KB
Sem ameaças
www.myelomasociety.org/about-us/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/about-us/#
144.3 KB
Sem ameaças
www.myelomasociety.org/grants/#
143.8 KB
Sem ameaças
www.myelomasociety.org/renew-membership/#
202.5 KB
Sem ameaças
www.myelomasociety.org/career-development-award/#
185.6 KB
Sem ameaças
www.myelomasociety.org/membership/#
142.7 KB
Sem ameaças
www.google.com/recaptcha/api.js?hl=en&&ver=7.0.4#038;render=explicit
976 B
Sem ameaças
player.vimeo.com/video/1122004834?h=91c3f1bf02
5.0 KB
Sem ameaças
www.myelomasociety.org/feed/mp3/#
34.1 KB
Sem ameaças
www.myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/#
143.3 KB
Sem ameaças
www.myelomasociety.org/events/23rd-ims-annual-meeting/#
147.7 KB
Sem ameaças
www.myelomasociety.org/events/novel-immune-therapies-workshop/#
144.8 KB
Sem ameaças
www.myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/#
149.2 KB
Sem ameaças
www.myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/#
146.8 KB
Sem ameaças
www.myelomasociety.org/advocacy/tmap/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/advocacy/tmap/#
144.4 KB
Sem ameaças
www.myelomasociety.org/awards/waldenstrom-award/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/awards/waldenstrom-award/#
146.8 KB
Sem ameaças
www.myelomasociety.org/awards/ken-anderson-young-investigator-award/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/awards/ken-anderson-young-investigator-award/#
146.6 KB
Sem ameaças
www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/#
146.5 KB
Sem ameaças
www.myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/#
147.3 KB
Sem ameaças
www.myelomasociety.org/officers/masahiro-abe-md-phd/#
145.3 KB
Sem ameaças
www.myelomasociety.org/officers/kenneth-anderson-md/#
146.6 KB
Sem ameaças
www.myelomasociety.org/officers/suzanne-lentzsch-md-phd/#
146.8 KB
Sem ameaças
www.myelomasociety.org/officers/katja-weisel-md/#
147.0 KB
Sem ameaças
www.myelomasociety.org/officers/19271/#
146.1 KB
Sem ameaças
www.myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/#
145.6 KB
Sem ameaças
www.myelomasociety.org/officers/philippe-moreau-md/#
145.2 KB
Sem ameaças
www.myelomasociety.org/officers/elena-zamagni-md-phd/#
146.5 KB
Sem ameaças
www.myelomasociety.org/officers/noopur-s-raje-md/#
145.0 KB
Sem ameaças
www.myelomasociety.org/officers/nikhil-c-munshi-md/#
147.3 KB
Sem ameaças
www.myelomasociety.org/officers/jesus-san-miguel-md-phd/#
145.7 KB
Sem ameaças
www.myelomasociety.org/officers/shaji-kumar-md/#
144.6 KB
Sem ameaças
www.myelomasociety.org/officers/maria-victoria-mateos-md-phd/#
145.9 KB
Sem ameaças
www.myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/#
146.6 KB
Sem ameaças
www.myelomasociety.org/officers/robert-a-kyle-md/#
145.8 KB
Sem ameaças
www.myelomasociety.org/about-us/officers/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/about-us/officers/#
151.2 KB
Sem ameaças
www.myelomasociety.org/about-us/member-details/about%3Ablank
60 B
Sem ameaças
www.myelomasociety.org/about-us/member-details/#
217.2 KB
Sem ameaças
Links externos e domínios
411
Ligações externas
Tudo limpo
1
Iframes
Limpo
27
Domínios referenciados
Tudo limpo
0
Recursos sinalizados
Nada detetado
http://browsehappy.com/Não sinalizado
http://myelomasociety.org/about-us/Não sinalizado
http://myelomasociety.org/about-us/member-details/Não sinalizado
http://myelomasociety.org/about-us/officers/Não sinalizado
http://myelomasociety.org/about:blankNão sinalizado
http://myelomasociety.org/advocacy/Não sinalizado
http://myelomasociety.org/advocacy/tmap/Não sinalizado
http://myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/Não sinalizado
http://myelomasociety.org/awards/Não sinalizado
http://myelomasociety.org/awards/bart-barlogie-young-investigator-award/Não sinalizado
http://myelomasociety.org/awards/ken-anderson-young-investigator-award/Não sinalizado
http://myelomasociety.org/awards/waldenstrom-award/Não sinalizado
http://myelomasociety.org/career-development-award/Não sinalizado
http://myelomasociety.org/contact/Não sinalizado
http://myelomasociety.org/donate/Não sinalizado
Mostrar mais 396...
http://myelomasociety.org/education/Não sinalizado
http://myelomasociety.org/events/Não sinalizado
http://myelomasociety.org/events/23rd-ims-annual-meeting/Não sinalizado
http://myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/Não sinalizado
http://myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/Não sinalizado
http://myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/Não sinalizado
http://myelomasociety.org/events/novel-immune-therapies-workshop/Não sinalizado
http://myelomasociety.org/glo-ims/Não sinalizado
http://myelomasociety.org/grants/Não sinalizado
http://myelomasociety.org/ims-connect/Não sinalizado
http://myelomasociety.org/ims-news-room/Não sinalizado
http://myelomasociety.org/imsound/Não sinalizado
http://myelomasociety.org/meeting-materials/Não sinalizado
http://myelomasociety.org/membership/Não sinalizado
http://myelomasociety.org/officers/19271/Não sinalizado
http://myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/Não sinalizado
http://myelomasociety.org/officers/elena-zamagni-md-phd/Não sinalizado
http://myelomasociety.org/officers/jesus-san-miguel-md-phd/Não sinalizado
http://myelomasociety.org/officers/katja-weisel-md/Não sinalizado
http://myelomasociety.org/officers/kenneth-anderson-md/Não sinalizado
http://myelomasociety.org/officers/maria-victoria-mateos-md-phd/Não sinalizado
http://myelomasociety.org/officers/masahiro-abe-md-phd/Não sinalizado
http://myelomasociety.org/officers/nikhil-c-munshi-md/Não sinalizado
http://myelomasociety.org/officers/noopur-s-raje-md/Não sinalizado
http://myelomasociety.org/officers/philippe-moreau-md/Não sinalizado
http://myelomasociety.org/officers/robert-a-kyle-md/Não sinalizado
http://myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/Não sinalizado
http://myelomasociety.org/officers/shaji-kumar-md/Não sinalizado
http://myelomasociety.org/officers/suzanne-lentzsch-md-phd/Não sinalizado
http://myelomasociety.org/publications/Não sinalizado
http://myelomasociety.org/renew-membership/Não sinalizado
http://myelomasociety.org/rwlkndntodz70pncjlz+vs5lfhfs7lixda/nQ6BMfy4NA2JV8GvaNOriauzE38L2WqrHhMJJUcx+XNd2b1cxprmEXCC5WRqcvN4kZNMzea4LDY%3DNão sinalizado
http://myelomasociety.org/translational-research-award/Não sinalizado
http://myelomasociety.org/zotknmvcufmka+gcznuu6s0sonmy8vvthz6jnd4wwup4krocefqzpoqm7cr93knvfnyeidjhbj8t7xaehzwvmjntmqex4cl9vwjx0/baf2tMms%3DNão sinalizado
http://tmap.myelomasociety.org/Não sinalizado
https://bsky.app/profile/myeloma-society.bsky.socialNão sinalizado
https://cdn.jsdelivr.net/npm/tsparticles@1.18.3/dist/tsparticles.min.jsNão sinalizado
https://challenges.cloudflare.com/turnstile/v0/api.js?onload%3DturnstileLoadNão sinalizado
https://events.jspargo.com/ims26/CUSTOM/DGHOProgram2026.pdfNão sinalizado
https://events.jspargo.com/ims26/CUSTOM/IMS2026Program.pdf?__hstc%3D113688920.2b677668b1c0d347e01494227127fa6c.1775135324106.1779466033070.1779705887942.56&%3B__hssc%3D113688920.1.1779705887942&%3B__hsfp%3Dbf1414f9ef3b88063871ea845a26dec4Não sinalizado
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarCentralAug.pdfNão sinalizado
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarCentralJul.pdfNão sinalizado
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarEastAug.pdfNão sinalizado
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarEastJun.pdfNão sinalizado
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarWestAug.pdfNão sinalizado
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarWestJul.pdfNão sinalizado
https://fonts.googleapis.com/css2?family%3DOpen+Sans:ital@0%3B1&%3Bfamily%3DPlayfair+Display:ital,wght@0,400%3B0,700%3B1,400%3B1,700&%3Bdisplay%3DswapNão sinalizado
https://fonts.gstatic.comNão sinalizado
https://ims26.myexpoonline.com/homeNão sinalizado
https://myeloma.wpengine.com/about-us/officers/Não sinalizado
https://myeloma.wpengine.com/wp-content/uploads/2021/02/COI-Policy-IMS.pdfNão sinalizado
https://myeloma.wpengine.com/wp-content/uploads/2021/03/IMSAltLogo.pngNão sinalizado
https://myelomasociety.flexigrant.com/startapplication.aspx?id%3D16381Não sinalizado
https://myelomasociety.org/grants/ims-career-development-award/Não sinalizado
https://myelomasociety.org/past-events/Não sinalizado
https://myelomasociety.org/privacy-policy/Não sinalizado
https://myelomasociety.org/publications/Não sinalizado
https://myelomasociety.org/wp-content/uploads/2021/03/PM-COVID-vaccination-in-MM-guidelines-The-Final.pdfNão sinalizado
https://player.vimeo.com/video/1122004834?h%3D91c3f1bf02Não sinalizado
https://www.eventcreate.com/e/communitywebinarseries2026Não sinalizado
https://www.eventcreate.com/e/fda-ims-joint-workshop2024Não sinalizado
https://www.eventcreate.com/e/imsdgho2026Não sinalizado
https://www.google.com/recaptcha/api.js?hl%3Den&%3B&%3Bver%3D7.0.4#038%3Brender%3DexplicitNão sinalizado
https://www.googletagmanager.com/gtag/js?id%3DAW-11265840522Não sinalizado
https://www.googletagmanager.com/gtag/js?id%3DGT-MK9LQQBNão sinalizado
https://www.gstatic.com/recaptcha/releases/XOqlk8PL_yVx6IdpLbpXdiLy/recaptcha__en.jsNão sinalizado
https://www.linkedin.com/company/19160726/admin/dashboard/Não sinalizado
https://www.myelomasociety.orgNão sinalizado
https://www.myelomasociety.org/Não sinalizado
https://www.myelomasociety.org/?p%3D18549Não sinalizado
https://www.myelomasociety.org/?p%3D18605Não sinalizado
https://www.myelomasociety.org/?p%3D18607Não sinalizado
https://www.myelomasociety.org/?p%3D18610Não sinalizado
https://www.myelomasociety.org/?page_id%3D2928&%3Bpreview%3DtrueNão sinalizado
https://www.myelomasociety.org/?post_type%3Dpodcast&%3Bp%3D18550&%3Bpreview%3DtrueNão sinalizado
https://www.myelomasociety.org/about-us/Não sinalizado
https://www.myelomasociety.org/about-us/member-details/Não sinalizado
https://www.myelomasociety.org/about-us/member-details/membership-information/Não sinalizado
https://www.myelomasociety.org/about-us/officers/Não sinalizado
https://www.myelomasociety.org/advocacy/Não sinalizado
https://www.myelomasociety.org/advocacy/tmap/Não sinalizado
https://www.myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/Não sinalizado
https://www.myelomasociety.org/award/amyloid-targeting-car-macrophage-therapy-against-al-amyloidosis/Não sinalizado
https://www.myelomasociety.org/award/ancestrality-of-genomic-alterations-in-multiple-myeloma-impact-on-the-clonal-evolution-and-on-the-minimal-residual-disease-dynamics/Não sinalizado
https://www.myelomasociety.org/award/apobec3b-as-a-biomarker-and-therapeutic-vulnerability-in-tp53-aberrant-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/application-of-mass-spectrometry-for-the-diagnosis-and-monitoring-of-real-life-patients-with-monoclonal-gammopathies/Não sinalizado
https://www.myelomasociety.org/award/armored-cars-to-overcome-sialylation-mediated-resistance-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/batmman-bone-marrow-adipocytes-in-the-multiple-myeloma-niche/Não sinalizado
https://www.myelomasociety.org/award/bcl2l1-armored-car-t-cells-overcome-exhaustion-and-enhance-persistence-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/bcma-inkt-car-for-the-treatment-of-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/biomarkers-for-monoclonal-gammopathy-of-undetermined-significance-mgus-and-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/bone-marrow-inflammation-as-driver-of-multiple-myeloma-persistence-and-relapse/Não sinalizado
https://www.myelomasociety.org/award/characterizing-the-emergence-of-t-cell-dysfunction-as-a-cause-of-therapy-failure-and-disease-progression-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/chimeric-antigen-receptor-t-cells-secreting-il-12-and-anti-il-6-to-enhance-responses-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/comprehensive-exploration-of-molecular-pathways-and-biomarkers-in-myeloma-induced-bone-disease-a-multi-omics-approach-for-personalized-therapeutic-management/Não sinalizado
https://www.myelomasociety.org/award/comprehensive-genomic-and-immune-characterization-of-response-and-resistance-to-daratumumab-based-quadruplet-induction-therapy/Não sinalizado
https://www.myelomasociety.org/award/convad-cart-next-generation-bcma-cart-cells-with-modular-targeting-capacities/Não sinalizado
https://www.myelomasociety.org/award/correlation-between-unfolded-protein-response-upr-markers-and-thrombosis-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/deciphering-the-human-plasma-cell-niche-and-its-transformation-in-multiple-myeloma-by-highly-multiplexed-tissue-imaging/Não sinalizado
https://www.myelomasociety.org/award/defining-the-risk-of-clonal-hematopoiesis-and-therapy-related-myeloid-neoplasms-in-multiple-myeloma-patients-receiving-asct-and-lenalidomide-maintenance/Não sinalizado
https://www.myelomasociety.org/award/democratizing-multiple-myeloma-car-t-cell-therapy-by-in-situ-programming-of-virus-specific-t-cells/Não sinalizado
https://www.myelomasociety.org/award/destiny-detecting-spatial-heterogeneity-in-multiple-myeloma-patients-through-a-liquid-biopsy-approach/Não sinalizado
https://www.myelomasociety.org/award/development-of-an-optimized-dual-targeted-tandem-vh-only-fully-human-car-to-generate-long-term-durable-remission-with-adoptive-cellular-therapy-for-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/development-of-novel-extracellular-vesicle-ev-exosome-based-treatment-for-multiple-myeloma-therapeutic-potential-of-mir125b-containing-osteoblast-derived-evs/Não sinalizado
https://www.myelomasociety.org/award/development-of-novel-targeted-therapies-for-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/discover-nutrients-understanding-the-relationship-between-nutrition-and-microbiome-in-mm/Não sinalizado
https://www.myelomasociety.org/award/discovering-and-targeting-unprecedented-mitochondrial-vulnerabilities-against-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/dissect-the-mechanisms-by-which-cst6n137d-enhances-the-efficacy-of-car-t-cell-therapy-in-myeloma/Não sinalizado
https://www.myelomasociety.org/award/dissecting-and-appraising-novel-mitochondrial-vulnerabilities-against-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/dissecting-the-functional-role-of-apobec3b-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/dissecting-the-mechanisms-of-multiple-myeloma-mm-resistance-to-natural-killer-nk-cells-and-the-role-of-nk-cells-macrophage-interaction-in-mm-immune-evasion/Não sinalizado
https://www.myelomasociety.org/award/early-detection-and-intervention-in-smoldering-multiple-myeloma-population-based-screening-and-treatment-edit-smm/Não sinalizado
https://www.myelomasociety.org/award/evaluating-nkp30-directed-bispecific-nk-cell-engagers-for-multiple-myeloma-therapy/Não sinalizado
https://www.myelomasociety.org/award/evaluation-of-single-nucleotide-polymorphisms-of-brca1-cdkn1a-tp53bp-and-xrcc1-in-multiple-myeloma-patients-undergoing-hematopoietic-stem-cells-transplant-and-their-association-with-clinical-outcom/Não sinalizado
https://www.myelomasociety.org/award/evaluation-of-single-nucleotide-variants-in-dna-repair-and-cell-cycle-control-genes-in-multiple-myeloma-patients-undergoing-hematopoietic-stem-cell-transplant-and-their-association-with-clinical-outco/Não sinalizado
https://www.myelomasociety.org/award/exploiting-translation-control-vulnerabilities-imposed-by-antibody-secretion-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/exploring-apobecs-as-therapeutic-vulnerabilities-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/flow-cytometry-as-a-tool-for-the-study-of-the-tumor-microenvironment-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/functional-screens-on-single-cell-transcriptomes-of-genotypically-defined-minimal-residual-disease-cells-to-unravel-specific-vulnerabilities-of-treatment-resistant-multiple-myeloma-future/Não sinalizado
https://www.myelomasociety.org/award/gck-a-new-therapeutic-target-for-undruggable-ras-in-myeloma-treatment/Não sinalizado
https://www.myelomasociety.org/award/gck-inhibition-as-a-new-therapeutical-approach-in-rasmut-myeloma-and-possible-strategy-to-overcome-therapy-resistance/Não sinalizado
https://www.myelomasociety.org/award/glutamine-metabolism-as-new-marker-and-diagnostic-tool-for-bone-diseases-in-mm-patients/Não sinalizado
https://www.myelomasociety.org/award/how-to-engage-t-cell-in-myeloma/Não sinalizado
https://www.myelomasociety.org/award/identify-high-risk-disease-in-multiple-myeloma-through-single-cell-detection-of-highly-proliferative-pr-cells/Não sinalizado
https://www.myelomasociety.org/award/identifying-mechanisms-of-response-and-resistance-to-bcma-car-t-therapy-in-multiple-myeloma-and-extramedullary-disease/Não sinalizado
https://www.myelomasociety.org/award/immagine/Não sinalizado
https://www.myelomasociety.org/award/immune-cell-contribution-to-drug-resistance-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/immunogenomics-guided-adaptive-cellular-therapies-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/immunotherapy-for-multiple-myeloma-a-new-generation-of-chimeric-antigen-receptors-and-immune-checkpoint-blockade/Não sinalizado
https://www.myelomasociety.org/award/improving-immune-surveillance-in-high-risk-multiple-myeloma-patients/Não sinalizado
https://www.myelomasociety.org/award/improving-prognosis-of-progression-risk-in-multiple-myeloma-precursors-through-single-cell-sequencing-based-genomic-and-immune-microenvironment-profiling-2/Não sinalizado
https://www.myelomasociety.org/award/investigating-creb1-signaling-as-a-novel-therapeutic-target-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/investigating-heme-induced-effector-car-t-cells-for-multiple-myeloma-therapy/Não sinalizado
https://www.myelomasociety.org/award/investigating-the-impact-of-vaccinations-on-the-development-and-course-of-monoclonal-gammopathies-a-comprehensive-analysis/Não sinalizado
https://www.myelomasociety.org/award/investigating-the-molecular-mechanisms-of-microenvironment-dependent-immune-escape-to-natural-killer-cells-in-myeloma-to-uncover-biomarkers-for-rational-combination-treatment-strategie/Não sinalizado
https://www.myelomasociety.org/award/investigation-of-the-molecular-mechanism-of-gck-inhibition-as-therapeutic-approach-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/liquid-biopsy-in-myeloma-to-inform-outcome-and-treatment-decisions/Não sinalizado
https://www.myelomasociety.org/award/modeling-unraveling-and-beating-acquired-resistance-to-bcma-and-gprc5d-targeted-agents-in-multiple-myeloma-2/Não sinalizado
https://www.myelomasociety.org/award/modeling-unraveling-and-beating-acquired-resistance-to-bcma-and-gprc5d-targeted-agents-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/molecular-characterization-and-therapeutic-targeting-of-protein-kinase-d2-in-t414-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/multimodal-investigation-of-myeloma-recognizing-t-cells-their-transcriptional-features-and-clinical-relevance/Não sinalizado
https://www.myelomasociety.org/award/nanobody-based-il-18-armored-bcma-baff-r-dual-car-t-cells-to-overcome-treatment-failure-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/novel-immunotherapy-investigation-and-characterization-of-immune-escape-mechanisms-to-natural-killer-cells-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/optimizing-melphalan-dose-among-older-adults-with-multiple-myeloma-receiving-autologous-stem-cell-transplantation/Não sinalizado
https://www.myelomasociety.org/award/patterns-of-relapse-from-complete-response-during-different-maintenance-strategies/Não sinalizado
https://www.myelomasociety.org/award/pnc-27-a-novel-effective-strategy-for-targeting-the-achilles-heel-of-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/role-of-flow-cytometry-and-especially-its-use-in-the-definition-of-the-measurable-residual-disease-mrd-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/shield-mm-a-modular-multiplex-shrna-platform-to-enhance-functional-persistence-of-academic-anti-bcma-car-t-cells-ari0002h-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/single-cell-dissection-of-autologous-apheresis-products-to-predict-successful-manufacturing-safe-application-and-response-to-chimeric-antigen-receptor-t-cells-in-newly-diagnosed-and-relapsed-myeloma/Não sinalizado
https://www.myelomasociety.org/award/spatial-and-deep-learning-approaches-to-predict-early-progression-in-smoldering-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/spatial-and-temporal-tumor-genomic-heterogeneity-in-extramedullary-multiple-myeloma-and-solitary-plasmacytoma-with-minimal-marrow-involvement/Não sinalizado
https://www.myelomasociety.org/award/systematic-functional-genomics-characterization-of-17p13del-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/targeting-collagen-lair1-for-improving-multiple-myeloma-therapeutic-efficacy/Não sinalizado
https://www.myelomasociety.org/award/targeting-inter-organelle-communication-to-arrest-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/targeting-loss-of-the-tumor-suppressor-tent5c-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/targeting-metabolic-switch-of-high-risk-multiple-myeloma-cells-towards-the-design-of-an-exploratory-approach-for-an-unmet-clinical-need/Não sinalizado
https://www.myelomasociety.org/award/targeting-tcf3-addiction-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/targeting-tf-cd142-as-a-new-target-for-car-nk-cell-immunotherapy-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/targeting-the-bone-marrow-niche-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/the-development-of-amyloid-subtype-specific-car-phagocytes-for-al-amyloidosis-therapy/Não sinalizado
https://www.myelomasociety.org/award/the-permissive-immune-microenvironment-is-a-critical-regulator-of-disease-progression-from-smm-to-overt-mm-and-defining-these-alterations-is-critical-for-the-development-of-translational-prognostic-a/Não sinalizado
https://www.myelomasociety.org/award/transforming-multiple-myeloma-care-in-sub-saharan-africa-developing-a-population-specific-next-generation-sequencing-panel-based-on-long-read-whole-genome-sequencing-to-enhance-treatment-outcomes-in/Não sinalizado
https://www.myelomasociety.org/award/uncovering-ferroptosis-mediated-immune-escape-in-del17p-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/unlocking-precision-medicine-in-refractory-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/award/usbcar-t-using-crispr-2-0-to-generate-universal-slamf7-bcma-car-t-cells-for-treating-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/awards/Não sinalizado
https://www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/Não sinalizado
https://www.myelomasociety.org/awards/ken-anderson-young-investigator-award/Não sinalizado
https://www.myelomasociety.org/awards/waldenstrom-award/Não sinalizado
https://www.myelomasociety.org/belantamab-mafodotin-bortezomib-and-dexamethasone-vs-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-overall-survival-analysis-and-updated-efficacy-outcomes-of-th/Não sinalizado
https://www.myelomasociety.org/belantamab-mafodotin-bortezomib-and-dexamethasone-vs-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-overall-survival-analysis-and-updated-efficacy-outcomes-of-th/#Não sinalizado
https://www.myelomasociety.org/career-development-award/Não sinalizado
https://www.myelomasociety.org/contact/Não sinalizado
https://www.myelomasociety.org/development-of-an-academic-car-t-in-mm-the-spanish-experience/Não sinalizado
https://www.myelomasociety.org/development-of-an-academic-car-t-in-mm-the-spanish-experience/#Não sinalizado
https://www.myelomasociety.org/do-we-need-pet-ct-to-assess-response-in-mm/Não sinalizado
https://www.myelomasociety.org/do-we-need-pet-ct-to-assess-response-in-mm/#Não sinalizado
https://www.myelomasociety.org/donate/Não sinalizado
https://www.myelomasociety.org/drug-access-in-brazil-equity-actions-between-public-and-private-health-systems/Não sinalizado
https://www.myelomasociety.org/drug-access-in-brazil-equity-actions-between-public-and-private-health-systems/#Não sinalizado
https://www.myelomasociety.org/education/Não sinalizado
https://www.myelomasociety.org/efficacy-and-safety-of-isa-krd-induction-before-response-adapted-consolidation-in-transplant-eligible-newly-diagnosed-multiple-myeloma-an-interim-analysis-of-the-ifm2020-02-midas-study/#Não sinalizado
https://www.myelomasociety.org/events/Não sinalizado
https://www.myelomasociety.org/events/23rd-ims-annual-meeting/Não sinalizado
https://www.myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/Não sinalizado
https://www.myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/Não sinalizado
https://www.myelomasociety.org/events/novel-immune-therapies-workshop/Não sinalizado
https://www.myelomasociety.org/feed/mp3/Não sinalizado
https://www.myelomasociety.org/findings-from-the-australian-and-new-zealand-myeloma-and-related-diseases-registry/Não sinalizado
https://www.myelomasociety.org/findings-from-the-australian-and-new-zealand-myeloma-and-related-diseases-registry/#Não sinalizado
https://www.myelomasociety.org/first-results-of-a-phase-1-first-in-human-dose-escalation-study-of-isb-2001-a-bcmaxcd38xcd3-targeting-trispecific-antibody-in-patients-with-relapsed-refractory-multiple-myeloma-rrmm/Não sinalizado
https://www.myelomasociety.org/first-results-of-a-phase-1-first-in-human-dose-escalation-study-of-isb-2001-a-bcmaxcd38xcd3-targeting-trispecific-antibody-in-patients-with-relapsed-refractory-multiple-myeloma-rrmm/#Não sinalizado
https://www.myelomasociety.org/frontline-therapy-for-transplant-ineligible-patients-the-european-perspective/Não sinalizado
https://www.myelomasociety.org/frontline-therapy-for-transplant-ineligible-patients-the-european-perspective/#Não sinalizado
https://www.myelomasociety.org/glo-ims/Não sinalizado
https://www.myelomasociety.org/grants/Não sinalizado
https://www.myelomasociety.org/grants/ims-awards-for-exemplary-abstracts/Não sinalizado
https://www.myelomasociety.org/grants/ims-career-development-award/Não sinalizado
https://www.myelomasociety.org/grants/international-myeloma-society-ims-and-paula-and-rodger-riney-foundation-translational-research-grant/Não sinalizado
https://www.myelomasociety.org/importance-of-patient-reported-symptoms-and-health-related-quality-of-life-for-drug-approval-in-mm/#Não sinalizado
https://www.myelomasociety.org/ims-connect/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-July-3-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-May-1-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-May-15-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-May-8-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-april-10/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-april-17-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-april-24-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-april-3-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-december-12-2025/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-december-19-2025/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-december-5-2025/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-february-13/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-february-20-2026Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-february-27-2026Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-february-6-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-january-16-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-january-2-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-january-23-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-january-30-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-january-9-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-june-12-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-june-19-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-june-26-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-june-5-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-march-13-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-march-27-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-march-6-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-may-22-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-may-29-2026/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-november-14-2025/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-november-21-2025/Não sinalizado
https://www.myelomasociety.org/ims-connect/ims-connect-november-28-2025/Não sinalizado
https://www.myelomasociety.org/ims-connect/march-20-2026/Não sinalizado
https://www.myelomasociety.org/ims-news-room/Não sinalizado
https://www.myelomasociety.org/ims-news-room/a-statement-from-ims-president-philippe-moreau-after-the-ims-myeloma-cure-summit-definitions-metrics-and-milestones/Não sinalizado
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-asco-and-eha-signal-a-pivotal-moment-in-multiple-myeloma-research/Não sinalizado
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-convenes-global-cure-summit-to-chart-the-scientific-path-to-a-myeloma-cure/Não sinalizado
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-launches-national-webinar-series-to-support-community-use-of-emerging-immunotherapies-in-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-opens-abstract-submissions-for-23rd-annual-meeting/Não sinalizado
https://www.myelomasociety.org/ims-news-room/international-myeloma-to-convene-global-experts-in-warsaw-for-4th-annual-workshop-on-genomics/Não sinalizado
https://www.myelomasociety.org/imsound/Não sinalizado
https://www.myelomasociety.org/isatuximab-lenalidomide-bortezomib-and-dexamethasone-induction-therapy-for-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma-final-progression-free-survival-analysis-of-part-1-of-a/Não sinalizado
https://www.myelomasociety.org/isatuximab-lenalidomide-bortezomib-and-dexamethasone-induction-therapy-for-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma-final-progression-free-survival-analysis-of-part-1-of-a/#Não sinalizado
https://www.myelomasociety.org/login/?action%3Dforgot_passwordNão sinalizado
https://www.myelomasociety.org/meeting-materials/Não sinalizado
https://www.myelomasociety.org/membershipNão sinalizado
https://www.myelomasociety.org/membership/Não sinalizado
https://www.myelomasociety.org/membership/directory/Não sinalizado
https://www.myelomasociety.org/membership/ims-journal/Não sinalizado
https://www.myelomasociety.org/officers/19271/Não sinalizado
https://www.myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/Não sinalizado
https://www.myelomasociety.org/officers/elena-zamagni-md-phd/Não sinalizado
https://www.myelomasociety.org/officers/jesus-san-miguel-md-phd/Não sinalizado
https://www.myelomasociety.org/officers/katja-weisel-md/Não sinalizado
https://www.myelomasociety.org/officers/kenneth-anderson-md/Não sinalizado
https://www.myelomasociety.org/officers/maria-victoria-mateos-md-phd/Não sinalizado
https://www.myelomasociety.org/officers/masahiro-abe-md-phd/Não sinalizado
https://www.myelomasociety.org/officers/nikhil-c-munshi-md/Não sinalizado
https://www.myelomasociety.org/officers/noopur-s-raje-md/Não sinalizado
https://www.myelomasociety.org/officers/philippe-moreau-md/Não sinalizado
https://www.myelomasociety.org/officers/robert-a-kyle-md/Não sinalizado
https://www.myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/Não sinalizado
https://www.myelomasociety.org/officers/shaji-kumar-md/Não sinalizado
https://www.myelomasociety.org/officers/suzanne-lentzsch-md-phd/Não sinalizado
https://www.myelomasociety.org/ongoing-clinical-trials-from-the-nordic-group/Não sinalizado
https://www.myelomasociety.org/ongoing-clinical-trials-from-the-nordic-group/#Não sinalizado
https://www.myelomasociety.org/optimal-therapy-for-young-patients-with-high-risk-disease-the-european-point-of-view/Não sinalizado
https://www.myelomasociety.org/optimal-therapy-for-young-patients-with-high-risk-disease-the-european-point-of-view/#Não sinalizado
https://www.myelomasociety.org/phase-2-registrational-study-of-anitocabtagene-autoleucel-for-the-treatment-of-patients-with-relapsed-and-or-refractory-multiple-myeloma-preliminary-results-from-the-immagine-1-trial/Não sinalizado
https://www.myelomasociety.org/phase-2-registrational-study-of-anitocabtagene-autoleucel-for-the-treatment-of-patients-with-relapsed-and-or-refractory-multiple-myeloma-preliminary-results-from-the-immagine-1-trial/#Não sinalizado
https://www.myelomasociety.org/phase-2-study-of-teclistamab-based-induction-regimens-in-patients-with-transplant-eligible-te-newly-diagnosed-multiple-myeloma-ndmm-results-from-the-gmmg-hd10-dsmm-xx-majestec-5-trial/Não sinalizado
https://www.myelomasociety.org/phase-2-study-of-teclistamab-based-induction-regimens-in-patients-with-transplant-eligible-te-newly-diagnosed-multiple-myeloma-ndmm-results-from-the-gmmg-hd10-dsmm-xx-majestec-5-trial/#Não sinalizado
https://www.myelomasociety.org/phase-3-study-of-teclistamab-tec-in-combination-with-lenalidomide-len-and-tec-alone-versus-len-alone-in-newly-diagnosed-multiple-myeloma-ndmm-as-maintenance-therapy-following-autologous-stem-cel/Não sinalizado
https://www.myelomasociety.org/phase-3-study-of-teclistamab-tec-in-combination-with-lenalidomide-len-and-tec-alone-versus-len-alone-in-newly-diagnosed-multiple-myeloma-ndmm-as-maintenance-therapy-following-autologous-stem-cel/#Não sinalizado
https://www.myelomasociety.org/prevention-of-infections-during-treatment-with-bispecific-antibodies-and-car-t-cells-in-multiple-myeloma/#Não sinalizado
https://www.myelomasociety.org/publications/Não sinalizado
https://www.myelomasociety.org/renew-membership/Não sinalizado
https://www.myelomasociety.org/resistance-to-bispecific-antibodies/Não sinalizado
https://www.myelomasociety.org/resistance-to-bispecific-antibodies/#Não sinalizado
https://www.myelomasociety.org/role-of-tandem-autologous-stem-cell-transplantation-for-the-treatment-of-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/role-of-tandem-autologous-stem-cell-transplantation-for-the-treatment-of-multiple-myeloma/#Não sinalizado
https://www.myelomasociety.org/safety-and-efficacy-of-standard-of-care-ciltacabtagene-autoleucel-cilta-cel-for-relapsed-refractory-multiple-myeloma-rrmm-real-world-experience-with-updated-follow-up/#Não sinalizado
https://www.myelomasociety.org/single-cell-analyses-of-bone-marrow-immune-microenvironment-in-rrmm-subjects-treated-with-mek1-2-inhibitors-reveal-irf1-mediated-ifn-pdl1-signaling-axes/Não sinalizado
https://www.myelomasociety.org/single-cell-analyses-of-bone-marrow-immune-microenvironment-in-rrmm-subjects-treated-with-mek1-2-inhibitors-reveal-irf1-mediated-ifn-pdl1-signaling-axes/#Não sinalizado
https://www.myelomasociety.org/single-cell-rna-sequencing-of-6-million-tumor-and-immune-cells-in-patients-with-plasma-cell-premalignancy-unveils-co-regulation-of-disease-progression-by-tumor-biology-and-immune-dysregulation/#Não sinalizado
https://www.myelomasociety.org/the-ifm2017-03-phase-3-trial-a-dexamethasone-sparing-regimen-with-daratumumab-and-lenalidomide-for-frail-patients-with-newly-diagnosed-multiple-myeloma/Não sinalizado
https://www.myelomasociety.org/the-ifm2017-03-phase-3-trial-a-dexamethasone-sparing-regimen-with-daratumumab-and-lenalidomide-for-frail-patients-with-newly-diagnosed-multiple-myeloma/#Não sinalizado
https://www.myelomasociety.org/translational-research-award/Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/css/style-simple-red.css?ver%3D4.14.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/css/style.basic.css?ver%3D4.14.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/js/min/plugin/merged/asl.min.js?ver%3D4787Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/custom-twitter-feeds/css/ctf-styles.min.css?ver%3D2.6.1Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/google-site-kit/dist/assets/js/googlesitekit-consent-mode-86cb52dcb9f2b27ed244.jsNão sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/basic.min.css?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/theme-components.min.css?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/theme.min.css?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/scripts-theme.min.js?ver%3D301fdc9aa6144168f3b854c4c2c8f6d3Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/utils.min.js?ver%3D3f278756f0a3032bed328ff6a9f6c01dNão sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/vendor-theme.min.js?ver%3D7c651d0ba638ce98b9c65141edddd567Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/conditional_logic.min.js?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/gravityforms.min.js?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/jquery.json.min.js?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/placeholders.jquery.min.js?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/browsers.min.css?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/formreset.min.css?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/formsmain.min.css?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/readyclass.min.css?ver%3D2.10.5Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/memberpress/css/ui/login.css?ver%3D1.12.17Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/memberpress/css/ui/theme.css?ver%3D1.12.17Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/memberpress/js/login.js?ver%3D1.12.17Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/podlove-podcasting-plugin-for-wordpress/css/admin-font.css?ver%3D4.5.4Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/podlove-podcasting-plugin-for-wordpress/css/frontend.css?ver%3D1.0Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/podlove-web-player/js/cache.js?ver%3D5.9.2Não sinalizado
https://www.myelomasociety.org/wp-content/plugins/podlove-web-player/web-player/embed.js?ver%3D5.9.2Não sinalizado
https://www.myelomasociety.org/wp-content/themes/myeloma-society/dist/scripts/main.js?ver%3D1778641861Não sinalizado
https://www.myelomasociety.org/wp-content/themes/myeloma-society/dist/styles/main.css?ver%3D1778641860Não sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/01/home3-1000x834.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/02/Jesus-San-Miguel-MD-PhD-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/02/Kenneth-Anderson-MD-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/02/Mateos-Maria-Victoria-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/02/Nikhil-C.-Munshi-MD-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/02/Philippe-Moreau-MD-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/02/Raje-Noopur-1-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/02/Robert-A.-Kyle-MD-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/02/Shaji-Kumar-MD-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/03/IMSMainLogo.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-180x180.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-192x192.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-32x32.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2022/09/211125_SANOFI_LOGO_RGB.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2022/09/AbbVie-Logo_Blue-002.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2022/11/GENE_LOCKUP_Primary_FullColor_RGB-002-2-1.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2022/11/legend_logo_533x260-002-1.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/08/shutterstock_775583896-745x419.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/2.-AbbVie-Logo-DigitalAbbVieLogo_Preferred-DigitalAbbVieLogo_Preferred_Black_TransparentBack-300x52.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/20th-IMS-Annual-Meeting-Abstract-Book.pdfNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/Abe-Headshot-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/FDAIMSWorkshop2024Program-1.pdfNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/FDA_IMS-Joint-Wkshp-780x390-1-745x390.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/JNJ_Logo_SingleLine_Red_RGB-1-002-300x28.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/ReGEN_Science-Tagline-002-300x70.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/Slide1-300x169.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/Usmani.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/Zamagni-Elena-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2023/10/bms_logo_150_rgb_pos-300x42.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/04/Ochi-headshot-1.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/05/TMAP-Logo-scaled.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/06/IMSound-Logo-for-site-scaled.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/06/IMSound-Logo-scaled.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/07/IMSound-Logo-only-v2.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/07/TMAP-Logo-scaled.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/08/JNJ_Logo_SingleLine_Red_CMYK-300x28.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/08/Practical-Insights-2024_1080-x-1080.jpg2_-745x419.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/10/AZ_RGB_H_COL-300x73.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/10/IMSAnnual2024Abstracts.pdfNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/10/Sanofi-logo-RGB-JPG-300x138.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2024/10/bms_logo_300_rgb_pos-300x41.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/04/GSK_Logo_Full_Colour_RGB-300x169.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/07/Full_Caribou_Logo_Dual_R-300x91.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004103-1-scaled.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004129-1-scaled.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004148-2-scaled.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/Chandramouli_Nagarajan.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/IMS-Program-and-Initiatives-2025-Prf9.pdfNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/IMSAnnual2025Abstracts.pdfNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/Lentzsch-Suzanne-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/Natalia-Schutz.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/09/Weisel-Katja-320x410.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/10/24IMSADA_01640-1000x750.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_001072_Panel_Precursor-1000x750.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_001681_Panel_Perrot-1000x568.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_003079_Audience-1000x696.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_004033_Poster-1000x750.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/12/GILEAD_KITE_Logo_Horiz_RGB_012622-300x93.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/12/IMS-2026-Graphics_940x789-745x419.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/12/Pfizer_BU_Oncology_Color_RGB-300x142.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2025/12/Roche_Logo_800px_Blue_RGB_Roche_Logo_RGB-3-300x156.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2026/03/Abbvie-Community-300x114.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2026/03/Community-Webinar-Graphics_940x789-1-745x419.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2026/03/Slide1-1-300x169.pngNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2026/03/Slide1-300x169.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2026/03/images-e1773728008617-300x60.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2026/05/IMS-GLO-Promos_1080x1080-1000x1000.jpgNão sinalizado
https://www.myelomasociety.org/wp-content/uploads/2026/07/IMS-2026-Media-Briefing-The-State-of-Multiple-Myeloma-Cure.pdfNão sinalizado
https://www.myelomasociety.org/wp-includes/css/dashicons.min.css?ver%3D7.0.4Não sinalizado
https://www.myelomasociety.org/wp-includes/js/dist/a11y.min.js?ver%3Daf934e5259bc51b8718eNão sinalizado
https://www.myelomasociety.org/wp-includes/js/dist/dom-ready.min.js?ver%3Da06281ae5cf5500e9317Não sinalizado
https://www.myelomasociety.org/wp-includes/js/dist/hooks.min.js?ver%3D7496969728ca0f95732dNão sinalizado
https://www.myelomasociety.org/wp-includes/js/dist/i18n.min.js?ver%3D781d11515ad3d91786ecNão sinalizado
https://www.myelomasociety.org/wp-includes/js/jquery/jquery-migrate.min.js?ver%3D3.4.1Não sinalizado
https://www.myelomasociety.org/wp-includes/js/jquery/jquery.min.js?ver%3D3.7.1Não sinalizado
https://www.myelomasociety.org/wp-includes/js/underscore.min.js?ver%3D1.13.8Não sinalizado
https://www.vanguardngr.com/casino/de/online-casino-ohne-verifizierung/Não sinalizado
https://x.com/Myeloma_SocietyNão sinalizado
browsehappy.comNão sinalizado
bsky.appNão sinalizado
cdn.jsdelivr.netNão sinalizado
challenges.cloudflare.comNão sinalizado
cloud.google.comNão sinalizado
developers.google.comNão sinalizado
docs.cloud.google.comNão sinalizado
events.jspargo.comNão sinalizado
fonts.googleapis.comNão sinalizado
fonts.gstatic.comNão sinalizado
google.comNão sinalizado
ims26.myexpoonline.comNão sinalizado
myeloma.wpengine.comNão sinalizado
myelomasociety.flexigrant.comNão sinalizado
myelomasociety.orgNão sinalizado
Mostrar mais 12...
player.vimeo.comNão sinalizado
support.google.comNão sinalizado
tmap.myelomasociety.orgNão sinalizado
vimeo.comNão sinalizado
www.eventcreate.comNão sinalizado
www.google.comNão sinalizado
www.googletagmanager.comNão sinalizado
www.gstatic.comNão sinalizado
www.linkedin.comNão sinalizado
www.myelomasociety.orgNão sinalizado
www.vanguardngr.comNão sinalizado
x.comNão sinalizado
<iframe title%3D"vimeo-player" src%3D"https://player.vimeo.com/video/1122004834?h%3D91c3f1bf02" width%3D"640" height%3D"360" frameborder%3D"0" allowfullscreen%3D"allowfullscreen">Não sinalizado
Visão geral de myelomasociety.org
Descrição de myelomasociety.org
myelomasociety.org parece ser o website oficial da International Myeloma Society, uma organização focada na investigação, educação, defesa e cuidados clínicos relacionados com o mieloma múltiplo. A identidade visual da página inicial, o título da página e as ligações de navegação indicam uma associação profissional ou organização de estilo sem fins lucrativos ao serviço de clínicos, investigadores e membros da comunidade do mieloma em todo o mundo.
Com base no conteúdo visível e nas secções associadas, o site parece fornecer informações sobre reuniões anuais, recursos educativos, iniciativas de investigação, prémios, esforços de defesa, adesão e donativos. O longo histórico de registo do domínio e as classificações relacionadas com saúde/educação/defesa são consistentes com a presença de uma sociedade médica ou ONG estabelecida, em vez de um site promocional temporário.
Avaliação de segurança de myelomasociety.org
No momento desta análise, nenhum motor de segurança reportou deteções para este domínio, e a análise de malware indicou não haver ficheiros assinalados entre as páginas verificadas. Além disso, o domínio não constava nas bases de dados de listas negras orientadas para malware e phishing que foram verificadas, e as ligações externas e domínios referenciados não apresentaram itens assinalados nos resultados da análise fornecidos.
Outros sinais contextuais também parecem favoráveis. O domínio está registado há muitos anos, o conteúdo do site corresponde ao de uma organização orientada para a saúde e a defesa, e a captura de ecrã mostra um website institucional coerente, em vez de padrões habitualmente associados a phishing, lojas falsas ou distribuição de malware. Com base nos dados disponíveis, não foram detetadas ameaças no momento desta análise.
Descrição técnica
O site está a utilizar um certificado SSL/TLS válido emitido pela Let's Encrypt, com o certificado apresentado como atual até 2026-10-02. Está alojado em infraestrutura Google Cloud nos Estados Unidos, utiliza o servidor web nginx, e os seus nameservers estão configurados através de infraestrutura relacionada com Google Domains.
O DNSSEC parece estar ativado e assinado, o que pode ajudar a proteger a integridade do DNS. Não foram evidentes preocupações técnicas de segurança imediatas nos dados da análise fornecidos, embora os detalhes exatos dos protocolos TLS suportados não estivessem disponíveis nesta captura.
Cadeia de redirecionamento HTTP
301
https://myelomasociety.org/
200
https://www.myelomasociety.org/
Informações do site
Popularidade
Cookies
Sem classificação
Posição Tranco
Fora do Top 1M
Histórico de posição (30 dias)
Sem dados de classificação disponíveis
3
cookies detetados
Essenciais0
Analítica2
Publicidade1
Social0
3
cookies primários
0
terceiro (rastreador)
Contestar esta pontuação
Para proprietários de sites
Acha que esta pontuação está incorreta?
Se é o proprietário do site e acredita que os resultados da análise contêm erros ou falsos positivos, pode enviar uma contestação para revisão manual. A nossa equipa responde normalmente em 1-2 dias úteis.
Falta mais um passo…
Para enviar a sua contestação para myelomasociety.org, clique na ligação de verificação que acabámos de enviar por e-mail. Após a verificação, faremos a revisão em 1-2 dias úteis.
Este relatório foi gerado automaticamente e é fornecido apenas para fins informativos. Os resultados baseiam-se numa análise pontual e podem conter falsos positivos ou dados incompletos. Isto não constitui uma auditoria ou certificação de segurança. Nenhum fornecedor no mercado pode garantir uma taxa de deteção de 100%. Se acredita que este relatório está incorreto, por favor
envie uma contestação.
Semelhantes analisados recentemente
Partilhe a sua experiência com este website. Era seguro? Encontrou algum problema?